Table of Content

1 Paroxysmal Nocturnal Hemoglobinuria Drug Market Overview
1.1 Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
1.2 Paroxysmal Nocturnal Hemoglobinuria Drug Market Segment by Type
1.2.1 Eculizumab
1.2.2 Ravulizumab
1.2.3 Others
1.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Type
1.3.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales Breakdown by Type (2018-2024)
2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Competition by Company
2.1 Global Top Players by Paroxysmal Nocturnal Hemoglobinuria Drug Sales (2018-2024)
2.2 Global Top Players by Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (2018-2024)
2.3 Global Top Players by Paroxysmal Nocturnal Hemoglobinuria Drug Price (2018-2024)
2.4 Global Top Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Paroxysmal Nocturnal Hemoglobinuria Drug Market Competitive Situation and Trends
2.5.1 Paroxysmal Nocturnal Hemoglobinuria Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Paroxysmal Nocturnal Hemoglobinuria Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Paroxysmal Nocturnal Hemoglobinuria Drug Market
2.8 Key Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Paroxysmal Nocturnal Hemoglobinuria Drug Status and Outlook by Region
3.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Historic Market Size by Region
3.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Value by Region (2018-2024)
3.2.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Forecasted Market Size by Region
3.3.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Value by Region (2024-2029)
3.3.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Paroxysmal Nocturnal Hemoglobinuria Drug by Application
4.1 Paroxysmal Nocturnal Hemoglobinuria Drug Market Segment by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Others
4.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Application
4.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales Breakdown by Application (2018-2024)
5 North America Paroxysmal Nocturnal Hemoglobinuria Drug by Country
5.1 North America Paroxysmal Nocturnal Hemoglobinuria Drug Historic Market Size by Country
5.1.1 North America Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Value by Country (2018-2024)
5.2 North America Paroxysmal Nocturnal Hemoglobinuria Drug Forecasted Market Size by Country
5.2.1 North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Value by Country (2024-2029)
6 Europe Paroxysmal Nocturnal Hemoglobinuria Drug by Country
6.1 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Historic Market Size by Country
6.1.1 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Value by Country (2018-2024)
6.2 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Forecasted Market Size by Country
6.2.1 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug by Region
7.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Historic Market Size by Region
7.1.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Value by Region (2024-2029)
8 Latin America Paroxysmal Nocturnal Hemoglobinuria Drug by Country
8.1 Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Historic Market Size by Country
8.1.1 Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Value by Country (2018-2024)
8.2 Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Forecasted Market Size by Country
8.2.1 Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug by Country
9.1 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Historic Market Size by Country
9.1.1 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Apellis Pharmaceuticals
10.1.1 Apellis Pharmaceuticals Company Information
10.1.2 Apellis Pharmaceuticals Introduction and Business Overview
10.1.3 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.1.5 Apellis Pharmaceuticals Recent Development
10.2 Alexion Pharmaceuticals Inc
10.2.1 Alexion Pharmaceuticals Inc Company Information
10.2.2 Alexion Pharmaceuticals Inc Introduction and Business Overview
10.2.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.2.5 Alexion Pharmaceuticals Inc Recent Development
10.3 Akari Therapeutics Plc
10.3.1 Akari Therapeutics Plc Company Information
10.3.2 Akari Therapeutics Plc Introduction and Business Overview
10.3.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.3.5 Akari Therapeutics Plc Recent Development
10.4 CinnaGen Co
10.4.1 CinnaGen Co Company Information
10.4.2 CinnaGen Co Introduction and Business Overview
10.4.3 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.4.5 CinnaGen Co Recent Development
10.5 Ra Pharmaceuticals Inc
10.5.1 Ra Pharmaceuticals Inc Company Information
10.5.2 Ra Pharmaceuticals Inc Introduction and Business Overview
10.5.3 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.5.5 Ra Pharmaceuticals Inc Recent Development
10.6 Amgen Inc
10.6.1 Amgen Inc Company Information
10.6.2 Amgen Inc Introduction and Business Overview
10.6.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.6.5 Amgen Inc Recent Development
10.7 Achillion Pharmaceuticals Inc
10.7.1 Achillion Pharmaceuticals Inc Company Information
10.7.2 Achillion Pharmaceuticals Inc Introduction and Business Overview
10.7.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.7.5 Achillion Pharmaceuticals Inc Recent Development
10.8 Alnylam Pharmaceuticals Inc
10.8.1 Alnylam Pharmaceuticals Inc Company Information
10.8.2 Alnylam Pharmaceuticals Inc Introduction and Business Overview
10.8.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.8.5 Alnylam Pharmaceuticals Inc Recent Development
10.9 F. Hoffmann-La Roche Ltd
10.9.1 F. Hoffmann-La Roche Ltd Company Information
10.9.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
10.9.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.9.5 F. Hoffmann-La Roche Ltd Recent Development
10.10 Novartis AG
10.10.1 Novartis AG Company Information
10.10.2 Novartis AG Introduction and Business Overview
10.10.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.10.5 Novartis AG Recent Development
10.11 Regeneron Pharmaceuticals Inc
10.11.1 Regeneron Pharmaceuticals Inc Company Information
10.11.2 Regeneron Pharmaceuticals Inc Introduction and Business Overview
10.11.3 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.11.5 Regeneron Pharmaceuticals Inc Recent Development
10.12 BIOCAD
10.12.1 BIOCAD Company Information
10.12.2 BIOCAD Introduction and Business Overview
10.12.3 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.12.5 BIOCAD Recent Development
10.13 Samsung Bioepis
10.13.1 Samsung Bioepis Company Information
10.13.2 Samsung Bioepis Introduction and Business Overview
10.13.3 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.13.5 Samsung Bioepis Recent Development
10.14 Amyndas Pharmaceuticals
10.14.1 Amyndas Pharmaceuticals Company Information
10.14.2 Amyndas Pharmaceuticals Introduction and Business Overview
10.14.3 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.14.5 Amyndas Pharmaceuticals Recent Development
10.15 Teva Pharmaceutical Industries Ltd.
10.15.1 Teva Pharmaceutical Industries Ltd. Company Information
10.15.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
10.15.3 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.15.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.16 LGM Pharma.
10.16.1 LGM Pharma. Company Information
10.16.2 LGM Pharma. Introduction and Business Overview
10.16.3 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.16.5 LGM Pharma. Recent Development
10.17 Lannett
10.17.1 Lannett Company Information
10.17.2 Lannett Introduction and Business Overview
10.17.3 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.17.5 Lannett Recent Development
10.18 NorthStar Rx LLC
10.18.1 NorthStar Rx LLC Company Information
10.18.2 NorthStar Rx LLC Introduction and Business Overview
10.18.3 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.18.4 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.18.5 NorthStar Rx LLC Recent Development
10.19 Abbott
10.19.1 Abbott Company Information
10.19.2 Abbott Introduction and Business Overview
10.19.3 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.19.5 Abbott Recent Development
10.20 Par Pharmaceutical
10.20.1 Par Pharmaceutical Company Information
10.20.2 Par Pharmaceutical Introduction and Business Overview
10.20.3 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Products Offered
10.20.5 Par Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Paroxysmal Nocturnal Hemoglobinuria Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Paroxysmal Nocturnal Hemoglobinuria Drug Industrial Chain Analysis
11.4 Paroxysmal Nocturnal Hemoglobinuria Drug Market Dynamics
11.4.1 Paroxysmal Nocturnal Hemoglobinuria Drug Industry Trends
11.4.2 Paroxysmal Nocturnal Hemoglobinuria Drug Market Drivers
11.4.3 Paroxysmal Nocturnal Hemoglobinuria Drug Market Challenges
11.4.4 Paroxysmal Nocturnal Hemoglobinuria Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Paroxysmal Nocturnal Hemoglobinuria Drug Distributors
12.3 Paroxysmal Nocturnal Hemoglobinuria Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Eculizumab
Table 2. Major Company of Ravulizumab
Table 3. Major Company of Others
Table 4. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (K Units)
Table 6. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share in Value by Type (2018-2024)
Table 9. Global Paroxysmal Nocturnal Hemoglobinuria Drug Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2024-2029) & (K Units)
Table 11. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Type (2024-2029)
Table 14. Global Paroxysmal Nocturnal Hemoglobinuria Drug Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (K Units)
Table 16. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units) by Type (2018-2024)
Table 18. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units) by Type (2018-2024)
Table 22. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Company (2018-2024) & (K Units)
Table 26. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Share by Company (2018-2024)
Table 27. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Paroxysmal Nocturnal Hemoglobinuria Drug Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Paroxysmal Nocturnal Hemoglobinuria Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Paroxysmal Nocturnal Hemoglobinuria Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Paroxysmal Nocturnal Hemoglobinuria Drug Market
Table 34. Key Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2018-2024) & (K Units)
Table 38. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2024-2029) & (K Units)
Table 43. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Region (2024-2029)
Table 46. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (K Units)
Table 49. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Paroxysmal Nocturnal Hemoglobinuria Drug Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2024-2029) & (K Units)
Table 54. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Application (2024-2029)
Table 57. Global Paroxysmal Nocturnal Hemoglobinuria Drug Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) (K Units)
Table 59. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) (K Units)
Table 61. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) (K Units)
Table 65. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2024) & (K Units)
Table 69. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2024-2029) & (K Units)
Table 73. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2024) & (K Units)
Table 77. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2024-2029) & (K Units)
Table 81. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Country (2024-2029)
Table 108. Apellis Pharmaceuticals Company Information
Table 109. Apellis Pharmaceuticals Introduction and Business Overview
Table 110. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 112. Apellis Pharmaceuticals Recent Development
Table 113. Alexion Pharmaceuticals Inc Company Information
Table 114. Alexion Pharmaceuticals Inc Introduction and Business Overview
Table 115. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 117. Alexion Pharmaceuticals Inc Recent Development
Table 118. Akari Therapeutics Plc Company Information
Table 119. Akari Therapeutics Plc Introduction and Business Overview
Table 120. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 122. Akari Therapeutics Plc Recent Development
Table 123. CinnaGen Co Company Information
Table 124. CinnaGen Co Introduction and Business Overview
Table 125. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 127. CinnaGen Co Recent Development
Table 128. Ra Pharmaceuticals Inc Company Information
Table 129. Ra Pharmaceuticals Inc Introduction and Business Overview
Table 130. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 132. Ra Pharmaceuticals Inc Recent Development
Table 133. Amgen Inc Company Information
Table 134. Amgen Inc Introduction and Business Overview
Table 135. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 137. Amgen Inc Recent Development
Table 138. Achillion Pharmaceuticals Inc Company Information
Table 139. Achillion Pharmaceuticals Inc Introduction and Business Overview
Table 140. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 142. Achillion Pharmaceuticals Inc Recent Development
Table 143. Alnylam Pharmaceuticals Inc Company Information
Table 144. Alnylam Pharmaceuticals Inc Introduction and Business Overview
Table 145. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 147. Alnylam Pharmaceuticals Inc Recent Development
Table 148. F. Hoffmann-La Roche Ltd Company Information
Table 149. F. Hoffmann-La Roche Ltd Introduction and Business Overview
Table 150. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 152. F. Hoffmann-La Roche Ltd Recent Development
Table 153. Novartis AG Company Information
Table 154. Novartis AG Introduction and Business Overview
Table 155. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 157. Novartis AG Recent Development
Table 158. Regeneron Pharmaceuticals Inc Company Information
Table 159. Regeneron Pharmaceuticals Inc Introduction and Business Overview
Table 160. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 162. Regeneron Pharmaceuticals Inc Recent Development
Table 163. BIOCAD Company Information
Table 164. BIOCAD Introduction and Business Overview
Table 165. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 167. BIOCAD Recent Development
Table 168. Samsung Bioepis Company Information
Table 169. Samsung Bioepis Introduction and Business Overview
Table 170. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 172. Samsung Bioepis Recent Development
Table 173. Amyndas Pharmaceuticals Company Information
Table 174. Amyndas Pharmaceuticals Introduction and Business Overview
Table 175. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 177. Amyndas Pharmaceuticals Recent Development
Table 178. Teva Pharmaceutical Industries Ltd. Company Information
Table 179. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 180. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 182. Teva Pharmaceutical Industries Ltd. Recent Development
Table 183. LGM Pharma. Company Information
Table 184. LGM Pharma. Introduction and Business Overview
Table 185. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 186. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 187. LGM Pharma. Recent Development
Table 188. Lannett Company Information
Table 189. Lannett Introduction and Business Overview
Table 190. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 191. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 192. Lannett Recent Development
Table 193. NorthStar Rx LLC Company Information
Table 194. NorthStar Rx LLC Introduction and Business Overview
Table 195. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 196. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 197. NorthStar Rx LLC Recent Development
Table 198. Abbott Company Information
Table 199. Abbott Introduction and Business Overview
Table 200. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 201. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 202. Abbott Recent Development
Table 203. Par Pharmaceutical Company Information
Table 204. Par Pharmaceutical Introduction and Business Overview
Table 205. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 206. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product
Table 207. Par Pharmaceutical Recent Development
Table 208. Key Raw Materials Lists
Table 209. Raw Materials Key Suppliers Lists
Table 210. Paroxysmal Nocturnal Hemoglobinuria Drug Market Trends
Table 211. Paroxysmal Nocturnal Hemoglobinuria Drug Market Drivers
Table 212. Paroxysmal Nocturnal Hemoglobinuria Drug Market Challenges
Table 213. Paroxysmal Nocturnal Hemoglobinuria Drug Market Restraints
Table 214. Paroxysmal Nocturnal Hemoglobinuria Drug Distributors List
Table 215. Paroxysmal Nocturnal Hemoglobinuria Drug Downstream Customers
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Paroxysmal Nocturnal Hemoglobinuria Drug Product Picture
Figure 2. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Eculizumab
Figure 6. Global Eculizumab Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Ravulizumab
Figure 8. Global Ravulizumab Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Type in 2022 & 2029
Figure 13. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Paroxysmal Nocturnal Hemoglobinuria Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Paroxysmal Nocturnal Hemoglobinuria Drug Revenue in 2022
Figure 25. Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application in 2022 & 2029
Figure 34. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturing Cost Structure
Figure 45. Paroxysmal Nocturnal Hemoglobinuria Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed